1215 related articles for article (PubMed ID: 17334012)
1. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties and clinical efficacy of a recently licensed systemic antifungal, caspofungin.
Maschmeyer G; Glasmacher A
Mycoses; 2005 Jul; 48(4):227-34. PubMed ID: 15982202
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin: the first representative of a new antifungal class.
Letscher-Bru V; Herbrecht R
J Antimicrob Chemother; 2003 Mar; 51(3):513-21. PubMed ID: 12615851
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin: a review of its use in the treatment of fungal infections.
McCormack PL; Perry CM
Drugs; 2005; 65(14):2049-68. PubMed ID: 16162025
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin: pharmacology, safety and therapeutic potential in superficial and invasive fungal infections.
Groll AH; Walsh TJ
Expert Opin Investig Drugs; 2001 Aug; 10(8):1545-58. PubMed ID: 11772269
[TBL] [Abstract][Full Text] [Related]
6. Caspofungin acetate for treatment of invasive fungal infections.
Pacetti SA; Gelone SP
Ann Pharmacother; 2003 Jan; 37(1):90-8. PubMed ID: 12503942
[TBL] [Abstract][Full Text] [Related]
7. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin.
Deresinski SC; Stevens DA
Clin Infect Dis; 2003 Jun; 36(11):1445-57. PubMed ID: 12766841
[TBL] [Abstract][Full Text] [Related]
10. The echinocandins.
Cappelletty D; Eiselstein-McKitrick K
Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin: a review of its use in oesophageal candidiasis, invasive candidiasis and invasive aspergillosis.
Keating G; Figgitt D
Drugs; 2003; 63(20):2235-63. PubMed ID: 14498760
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin: first approved agent in a new class of antifungals.
Johnson MD; Perfect JR
Expert Opin Pharmacother; 2003 May; 4(5):807-23. PubMed ID: 12740003
[TBL] [Abstract][Full Text] [Related]
13. Echinocandins in the management of invasive fungal infections, Part 2.
Morris MI; Villmann M
Am J Health Syst Pharm; 2006 Oct; 63(19):1813-20. PubMed ID: 16990627
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin for invasive fungal infections: combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation.
Pancham S; Hemmaway C; New H; Albert E; Dokal I; Roberts IA; McCloy M
Pediatr Transplant; 2005 Apr; 9(2):254-7. PubMed ID: 15787803
[TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of properties and clinical efficacy of the echinocandins.
Kim R; Khachikian D; Reboli AC
Expert Opin Pharmacother; 2007 Jul; 8(10):1479-92. PubMed ID: 17661730
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin acetate: an antifungal agent.
Hoang A
Am J Health Syst Pharm; 2001 Jul; 58(13):1206-14; quiz 1215-7. PubMed ID: 11449878
[TBL] [Abstract][Full Text] [Related]
17. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
19. Emerging echinocandins for treatment of invasive fungal infections.
Turner MS; Drew RH; Perfect JR
Expert Opin Emerg Drugs; 2006 May; 11(2):231-50. PubMed ID: 16634699
[TBL] [Abstract][Full Text] [Related]
20. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]